Game-Changing Launch: "Olivia" Health App The more significant driver of Tempus' rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge ...

On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI and Coinbase Global ... Actors Who Refused Game Of Thrones Roles Stock Market Correction: 2 Brilliant ...

On May 1, 2025, the American Foundation for Suicide Prevention (AFSP) will hold its 36th annual Lifesaver's Gala at Jazz at Lincoln Center in New York City. AFSP is a leading suicide prevention ...

Detailed price information for Tempus Capitalinc (TEMP-CN) from The Globe and Mail including charting and trades.

Wilmatm, the trailblazing AI-powered practice management system designed specifically for ABA therapy practices, announced the launch of its fully integrated Electronic Visit Verification (EVV) ...

CHICAGO, April 29, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication ...

Gifting allows recipients to access the article for free. Tempus AI said it will work with AstraZeneca and Pathos AI to build a multimodal foundation model in oncology that can gather biological ...

Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear ...

BTIG analyst Mark Massaro has initiated coverage on Tempus AI (TEM), with a Buy rating and a price target of $60, implying 48.3% upside potential. The analyst views TEM’s AI applications and ...

Tempus AI announces a multi-year collaboration with AstraZeneca and Pathos AI to build a multimodal foundation model in oncology. Tempus says the collaboration includes $200 million in data ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and comprehensive generative artificial intelligence model for oncology.